New inhibitors of HDAC to purge latent HIV-1 reservoir

Epigenomics

Volumn 2, Issue 4, 2010, Pages 505-506

  Hejnar, Jiri ^a   Hirsch, Ivan ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BELINOSTAT; CG 05; CG 06; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GIVINOSTAT; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METACEPT 1; METACEPT 3; MRK 1; PROTEIN KINASE LCK; PROTEIN P300; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ACETYLATION; ANTIVIRAL ACTIVITY; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; ENZYME INHIBITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS REACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77955442032     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.38     Document Type: Short Survey

References (9)

1. Archin NM, Keedy KS, Espeseth A et al.: Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. Aids 23, 1799 - 1806 (2009).
2. du Chene I, Basyuk E, Lin YL et al.: Suv39H1 and HP1g are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26, 424-435 (2007).
3. Blazkova J, Trejbalova K, Gondois-Rey F et al.: CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5, E1000554 (2009).
4. Keedy KS, Margolis DM: Therapy for persistent HIV. Trends Pharmacol. Sci. 31, 206-211 (2010).
5. Yang HC, Shen L, Siliciano RF, Pomerantz JL: Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc. Natl Acad. Sci. USA 106, 6321-6326 (2009).
6. Treand C, du Chene I, Bres V et al.: Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J. 25, 1690-1699 (2006).
7. Choi BS, Lee HS, Oh YT et al.: Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1. Aids 24, 609-611 (2010).
8. Matalon S, Palmer BE, Nold MF, Furlan A, Kassu A, et al.: The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro. J. Acquir. Immune Defic. Syndr. 54, 1-9 (2010).
9. Shehu-Xhilaga M, Rhodes D, Wightman F et al.: The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells. Aids 23, 2047-2050 (2009).